Eisenhower Health Reaches Nearly 300 Monarch Cases
Innovative technology for lung cancer diagnosis
“Lung cancer is the leading cause of cancer deaths worldwide, in part because it has no symptoms in its early stages. Because the Monarch Platform provides improved reach, vision and control for bronchoscopic procedures, it holds potential to help us to make a diagnosis earlier,” says Justin Thomas, MD, who is Board Certified in Pulmonary Disease, Interventional Pulmonary Disease, Internal Medicine and Critical Care Medicine, and the Director of the Bronchoscopy Laboratory, Eisenhower Health.
More than 90 percent of people diagnosed with lung cancer do not survive the disease, in part because it is often found at an advanced stage. However, early detection using low dose computed tomography (LDCT) scanning can help save lives with early detection and intervention. Eisenhower offers lung cancer screening to evaluate current and former smokers for their risk of lung cancer. Combined with a multidisciplinary team of experts and advanced technology like the Monarch, Eisenhower has made a commitment to finding lung cancer in its earliest stages for the betterment of the community.
To determine if you’re a candidate for lung cancer screening, call Eisenhower’s Lung Cancer Screening Program at 760.837.8880.